HASBROUCK HEIGHTS, N.J., Oct. 31, 2011 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (Nasdaq:NYMX) is pleased to announce that a presentation on the long-term results of NX-1207 treatment for benign prostatic hyperplasia (BPH) was given at the North Eastern Section of the American Urological Association by Dr. Barrett E. Cowan on Friday afternoon in New Orleans. Dr. Cowan, of Denver, CO, gave a moderated poster presentation at 3:36 p.m. (Central time) on Friday, October 28 with data from U.S. patients given NX-1207 in the past 7 years.
